​Metabiota

Cohort: Cohort 5, 2020 

Focus in insurance value chain/workflow: Point of underwriting 

Specific lines of business supported: Speciality  

Founded: 2008 

Status: Acquired*, still in insurance 

Company type: Data provider, Data models 

*Metabiota’s data and analytics technology and team, the part of Metabiota that participated in the Lloyd’s Lab Accelerator, were acquired by Ginkgo Bioworks in 2022. 

Head office: USA 

Main global offices: USA 

Locations served: Global 

Employee count: 11-100 

Metabiota is focused on quantifying and mitigating epidemic and pandemic risk. It has worked with the insurance industry to provide data and models for epidemic and pandemic insurance products. Metabiota's data and analytics technology and team, including epidemiological risk models, were acquired by Ginkgo Bioworks in 2022. 

Primary way aimed to improve insurance processes and tools whilst in the Accelerator: New sources of risk insight - data or models  

Metabiota developed a prototype tool for insurers in the Accelerator, which included a customised epidemic warning system, a COVID risk index for exposure management and a risk modelling tool for underwriting.